加速从第3阶段结核病瘤中恢复的措施:结核病瘤手术和恢复方法
Jiakun Liu1, Yanchao Luan1, Qingsong Han1
1Department of Thoracic Surgery, Hebei Chest Hospital, Hebei Provincial Key Laboratory of Pulmonary Disease, 372 Shengli North Street, Shijiazhuang, Hebei, 050000, People's Republic of China.
Perioperative medicine (London, England)
|April 17, 2025
概括
视频辅助胸腔镜皮层切割 (VATD) 与手术后增强恢复 (ERAS) 结合,显著减少住院时间,并改善第三阶段结核突患者的治疗结果. 这种方法提供了一个安全有效的治疗策略.
科学领域:
- 胸部外科手术 胸部外科手术
- 传染病 传染病 传染病
- 关键护理医学 关键护理医学
背景情况:
- 第三阶段的结核病带来了重大的治疗挑战.
- 优化手术和康复方案对于患者的治疗结果至关重要.
研究的目的:
- 评估视频辅助胸腔镜皮层切割 (VATD) 和手术后增强康复 (ERAS) 在III阶段结核病患者的综合效应.
- 将这些策略与传统的胸切除术 (TD) 和传统的恢复程序 (TRP) 相比较.
主要方法:
- 这项研究涉及360名参与者,分为四组:TD+TRP,TD+ERAS,VATD+TRP和VATD+ERAS.
- 评估手术期间和术后的结果,包括手术的持续时间,血液损失,排水,红细胞沉积率 (ESR),住院时间 (LOS) 和疼痛.
- 多变量分析以确定长期LOS的风险因素.
主要成果:
- 与TD相比,VATD和ERAS显著减少了手术持续时间,血液损失,术后排水,ESR,LOS和疼痛.
- 两组之间没有观察到术后并发症发生率的显著差异.
- VATD,ERAS和手术前的抗结核治疗与LOS相反相关.
结论:
- VATD和ERAS的结合提供了一种安全有效的方法来管理III阶段的结核病.
- 实施VATD和ERAS显著改善了患者的治疗结果,并减少了住院时间.
相关概念视频
01:28Pulmonary Tuberculosis V
150
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
150
01:26Pulmonary Tuberculosis IV
123
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
123
01:27Pneumothorax-II
106
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
106
01:28Pulmonary Tuberculosis II
195
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
195
01:26Flail Chest-II
136
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
136
01:28Pneumonia IV: Management
264
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
264